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Abstract
Background: In an individually randomised controlled trial where the treatment is delivered by a health professional
it seems likely that the effectiveness of the treatment, independent of any treatment effect, could depend on the skill,
training or even enthusiasm of the health professional delivering it. This may then lead to a potential clustering of the
outcomes for patients treated by the same health professional, but similar clustering may not occur in the control
arm. Using four case studies, we aim to provide practical guidance and recommendations for the analysis of trials with
some element of clustering in one arm.
Methods: Five approaches to the analysis of outcomes from an individually randomised controlled trial with
clustering in one arm are identified in the literature. Some of these methods are applied to four case studies of
completed randomised controlled trials with clustering in one arm with sample sizes ranging from 56 to 539. Results
are obtained using the statistical packages R and Stata and summarised using a forest plot.
Results: The intra-cluster correlation coefficient (ICC) for each of the case studies was small (<0.05) indicating little
dependence on the outcomes related to cluster allocations. All models fitted produced similar results, including the
simplest approach of ignoring clustering for the case studies considered.
Conclusions: A partially clustered approach, modelling the clustering in just one arm, most accurately represents the
trial design and provides valid results. Modelling homogeneous variances between the clustered and unclustered arm
is adequate in scenarios similar to the case studies considered. We recommend treating each participant in the
unclustered arm as a single cluster. This approach is simple to implement in R and Stata and is recommended for the
analysis of trials with clustering in one arm only. However, the case studies considered had small ICC values, limiting
the generalisability of these results.
Keywords: Clustering, Randomised controlled trial, Statistical models, Therapist effects, Individually clustered
randomised controlled trials
Background
Randomised controlled trials (RCTs) are commonly used
to evaluate the efficacy of healthcare treatments where
patients are randomised to receive care from the same
source; for example a health professional such as a nurse,
therapist, general practitioner (GP) or surgeon. There
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are two main types of RCTs: group/cluster randomised
controlled trials (cRCTs) and individually randomised
controlled trials (iRCTs). Cluster RCTs randomise groups
or clusters (of individuals) to the treatment arms; for
example GP practices, schools or communities whilst
iRCTs randomise individual patients [1, 2]. In a cRCT, for
example, where patients in each treatment arm receive
one of two group based interventions, we might expect
patients in the same group to experience similar outcomes
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purely as a result of their group allocation. It is important
to try and account for this cluster or group effect when
designing and analysing the data.
RCTswhere individuals are randomised are not immune
to this clustering effect either. In an iRCT where the treat-
ment is delivered by a health professional it seems likely
that the effectiveness of the treatment, independent of any
treatment effect, could depend on the skill, training or
even enthusiasm of the health professional delivering it.
This may then lead to a potential clustering of the out-
comes for patients treated by the same health professional
or who received treatment as a group. Alternatively a sin-
gle therapist may deliver an intervention to a sample of
patients on an individual basis while another therapist
delivers the intervention to a different sample of patients.
We might expect there to be clustering in the patients
who received treatment from the same therapist. In both
cRCTs and iRCTs with clustering we can measure the
extent to which outcomes within the same cluster may
depend on each other using the intra-cluster correlation
coefficient (ICC) [2].
If the outcomes are clustered then the conventional sta-
tistical methods for analysing RCT outcome data, such as
an independent two sample t-test to compare the mean
outcomes between the treatment and control groups, may
not be appropriate as the methods assume the observed
outcomes on different patients are independent [3]. When
there is clustering there is a lack of independence among
the outcomes. When using conventional statistical meth-
ods this may lead to underestimation of the standard
error for the treatment effect estimate, narrower confi-
dence limits and hence larger values for the test-statistic
(the ratio of the treatment estimate to its standard error)
and smaller P-values. The extent to which the results are
affected depends on the average cluster size in the trial
and the magnitude of the ICC [4]. For example a high ICC
(≥ 0.05) may not greatly impact the results if the average
size of the clusters is small and a low ICC (< 0.05) may
have a large impact on the results if the average cluster
size is large. If we do not use appropriate methods to allow
for this we can underestimate the standard error and over-
estimate the significance of results. Furthermore, there is
a reduction in the evaluable sample size and so the power
of the study to detect a treatment effect decreases.
Using the nomenclature of Baldwin [5], the clustering
that arises in iRCTs can be split into two categories, fully
clustered and partially clustered. A fully clustered trial is
one with elements of clustering that span both arms of the
trial. An example of a fully clustered trial is one compar-
ing homeopathic remedy with placebo for the treatment of
chronic fatigue syndrome [6]. Patients were assigned to a
homeopath and then within each homeopath the patients
were randomly assigned to either the treatment or control.
As patients on both treatments saw the same homeopath
there is clustering by homeopath in each arm of trial.
Partially clustered designs describes a trial where clus-
tering occurs in just one of the arms of the trial. An
example of a partially clustered design is a trial com-
paring acupuncture with usual care for the treatment of
persistent non-specific low back pain [7]. Patients in the
treatment armwere treated by one of the trial acupunctur-
ists. Clustering occurs in one arm of the trial only, where
a health professional-given treatment is being compared
with usual care. There is clustering by heath professional
in the treatment arm but no equivalent clustering in the
control arm (Fig. 1).
This paper reviews and describes the statistical methods
for analysing outcomes from an iRCT with some element
of clustering in one arm. We focus on trials with contin-
uous outcomes and assume the clustering occurs in the
Fig. 1 Schematic of a trial with clustering in only one arm (the treatment arm) where n1, . . . , nm is the number of patients in them treatment
clusters (clusters are not necessarily of equal size but this is often fixed in advance) and l is the number of subjects in the control arm
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treatment arm only. We explore the performance of all
the models including naïve approaches that were imple-
mented in our case studies prior to the development of
more sophisticated methods. We provide practical guid-
ance and recommendations for the analysis of iRCTs with
some element of clustering in only one arm.
Methods
Literature search
A comprehensive literature search was used to identify
published work on clustering in iRCTs. A search of the
database MEDLINE was conducted on 1st August 2014.
The following search criteria were implemented:
‘cluster analysis’ AND
‘Randomised controlled trials as topic
(mt, sn)’ OR
‘Clinical Trials as topic (mt, sn)’ OR
‘Research and Design (mt, sn)’
Two statisticians (LF and EL) hand searched the articles
independently based on titles, abstracts and where neces-
sary the full article, to identify relevant results. Relevant
articles contained details of RCTs with clustering in one
arm or methods used to analyse such trials. In addition to
the database search, papers known by the authors to be
relevant were included. Researchers known to be work-
ing in this area were contacted to identify unpublished or
ongoing work.
A consensus decision was then made between LF and
EL as to relevant articles. This list was then reviewed
and summarised, identifying the most relevant articles for
this project - those describing methodology for handling
clustering in one arm of iRCTs.
Literature search results
The MEDLINE search identified 353 articles. After the
initial hand searching exercise 22 (19 from the MEDLINE
search and three from other sources) were shortlisted and
17 were included in the list of relevant articles. These
articles included methodological and application papers
providing methods for the analysis of trials containing
clustering in one arm and are referenced throughout.
Models
The following models were selected based on the findings
of the literature search. The general notation is as follows;
y denotes the continuous outcome, i is the patient indica-
tor, j is the cluster indicator, t is the treatment indicator
variable, β0 is the intercept and θ is treatment effect.
Simple regression
The most straightforward and naïve option for the anal-
ysis of trials with clustering in one arm is to ignore
clustering and use a simple linear regression model. This
model assumes observations within the same treatment
arm and cluster are independent. Here yi is a continuous
outcome for patient i, ti is the treatment indicator vari-
able (t = 0 for control and t = 1 for the treatment arm)
for patient i, θ is the treatment effect, i are Normally dis-
tributed errors with mean zero and residual variance σ 2 .
This represents the patient level variation.
yi = β0 + θ ti + i, (1)
i ∼ N
(
0, σ 2
)
. (2)
Although this model is simple to implement and com-
mon in practice it may give incorrect results as the inde-
pendence assumption of the linear regression model is
violated [8]; standard errors of parameter estimates and
the p-value are likely to be smaller than they should be [2].
This will depend on the level of clustering as measured by
the ICC and the average cluster size.
Imposing clustering in the control arm
Rather than ignoring the clustering in the trial we can
account for it in the model used for analysis. As there is
clustering in just one arm of the trial, one option is to
impose clusters on the control arm that in reality do not
exist. This will allow the implementation of methods used
in the analysis of cRCTs with clustering in both arms.
There are different options for imposing clusters (j) in the
control arm. Table 1 gives three different options where l
is the number of participants and k is the number of arbi-
trary clusters in the control arm. The first option treats
the control arm as a large artificial cluster of size one [9];
the second option treats each individual within the control
arm as a cluster of size one with j = l clusters in the con-
trol arm [5, 8, 10]. Both approaches may cause problems
when estimating the ICC as, in theory, it is not possible
to estimate between cluster variability in the control arm
(Option 1, Table 1) and within cluster variability in the
control arm (Option 2, Table 1). However, in practice, the
exclusive person-to-person variability in the control arm
is artificially partitioned into the between and within clus-
ter components that occur with the treatment arm [5].
The third option overcomes the issue of estimating the
ICC. We create artificial-random clusters in the control
arm as in Option 3 (Table 1) [9]. Consideration may be
given to the number of arbitrary clusters (k) to minimise
bias in the estimation of treatment effect. There is paucity
Table 1 Different options for imposing clustering of controls
Option Control Treatment
1 j = 0 j = 1, . . . , J
2 j = 1, . . . , l j = l + 1, . . . , J
3 j = 1, . . . , k j = k + 1, . . . , J
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of literature guiding the optimum choice of the artificial-
cluster sizes, hence for pragmatic and simplicity reasons
k could be chosen to ensure cluster size is roughly equal
across treatment arms.
Cluster as a fixed effect
It is possible to account for clustering by including cluster
as a fixed covariate [5]; treating cluster coefficients as nui-
sance parameters. In Eq. 3 yij is the outcome for patient i
in cluster j, βj is the cluster effect, cj is the cluster indicator.
yij = β0 + θ tij +
J∑
j=1
βjcj + i, (3)
i ∼ N
(
0, σ 2
)
. (4)
While the fixed effect model may appear simple, fitting
the fixed effects model is not straightforward as the model
will be over-fitted; not all parameters in the model can
be estimated since within each cluster each participant
receives only the intervention or the control [11]. Conse-
quently, by setting one cluster to be the reference category
the between cluster treatment effect cannot be easily esti-
mated. There is no cross classification for treatment arm.
While options are available for fitting this model, we do
not advocate this approach [5]. The fixed effects model
does not truly reflect the study design. Therefore we will
not consider the model further in this paper.
Cluster as a random effect
Using a random effects model mitigates some of the lim-
itations of the fixed effects model. The inclusion of a
random cluster effect adds just one parameter for estima-
tion in the model, rather than J − 1 parameters as in Eq. 3
[12]. This increases the degrees of freedom and allows
exploration of the different sources of variability; between
and within cluster. In this model we fit a random intercept
for each cluster (uj) and assume it is Normally distributed
with zero mean and cluster effect variance (σ 2u ). Here, ij
is the patient level variation for the ith patient in the jth
cluster.
yij = β0 + θ tij + uj + ij, (5)
uj ∼ N
(
0, σ 2u
)
, (6)
ij ∼ N
(
0, σ 2
)
. (7)
Again, as with Eq. 3 the imposed clustering of the
control arm must be selected (Table 1, Options 1 to 3).
Modelling clustering in one arm
Imposing clustering in the control arm is theoretically not
an ideal solution [5]. Alternatively we can consider mod-
els that do not force any clustering on the ‘unclustered’
control arm, instead we model just the clustering in the
treatment arm. Subjects in the control arm are assumed
to be independent [5]. As such the ICC is allowed to vary
between the intervention and the control arm. Here the
ICC in the control arm is modelled to be zero and in
the intervention arm is modelled using Eqs. 19 and 20
given later. This partially clustered approach [8, 10, 13],
more accurately reflects the nature of the clustering in the
trial design [5], so is seemingly preferable to the forcing
clustering methods.
Partially clusteredmodel
In this model we confine the random effect to the treat-
ment arm only, and hence do not need to configure
artificial-clusters as in Table 1.
yij = β0 + θ tij + tijuj + ij, (8)
uj ∼ N
(
0, σ 2u
)
, (9)
ij ∼ N
(
0, σ 2
)
. (10)
We define a random slope model, however when writ-
ing out the models for the two levels of tij we can see this
essentially amounts to a random intercept for each cluster
in the treatment arm only (Eq. 11) and one intercept for
the unclustered control arm (Eq. 12).
For the treatment arm (tij = 1) :
yij = β0 + θ + uj + ij.
(11)
For the control arm (tij = 0) :
yij = β0 + ij. (12)
Heteroskedastic individual level errors
In the partially clustered model (Eq. 8) the individual
level errors ij have the same variance in the control and
the treatment arm - hence the model is homoscedastic.
An extension of this allows for different individual level
errors in the two treatment arms. In a trial with thera-
pists delivering an intervention in the treatment arm and
no intervention in the control arm we might expect par-
ticipants in the treatment arm to vary in a different way
to those participants in the control arm. The outcome
might be more homogeneous in participants in the treat-
ment arm as between therapist variation is small due to
adherence strict protocols for treatment implementation.
It is possible to extend the partially clustered approach
to allow for heteroskedastic errors between the treatment
arms [5, 8, 13]. The intervention arm varies differently to
the control arm. Here
yij = β0 + θ tij + tijuj + (1 − tij)rij + tijij, (13)
rij ∼ N
(
0, σ 2r
)
, (14)
uj ∼ N
(
0, σ 2u
)
, (15)
ij ∼ N
(
0, σ 2
)
. (16)
Flight et al. BMCMedical ResearchMethodology  (2016) 16:165 Page 5 of 13
For the treatment arm the cluster level error is uj and
the individual level error is ij (Eq. 17) and in the control
arm the individual level error is rij (Eq. 18).
For the treatment arm
(
tij = 1
)
:
yij =β0 + θ + uj + ij. (17)
For the control arm
(
tij = 0
)
:
yij =β0 + rij. (18)
This model can reveal whether individuals become
more homogeneous in their attitudes and behaviours as a
function of treatment arm membership [8].
A summary of the models that can be used in the
analysis of iRCT with clustering in one arm is given in
Fig. 2.
For the random effects, partially clustered and het-
eroskedastic models it is possible to estimate the ICC to
measure the overall level of clustering in the trial across
both arms [2]. For the random effects and partially clus-
tered models we use
ICC = σ
2
u
σ 2u + σ 2
. (19)
The heteroskedastic model requires an additional term
in the denominator as we have now allowed the residual
variance to differ between the treatment and control arms.
This formula was adapted from the work of Roberts (2010)
[14] on nested therapist designs
ICC = σ
2
u
σ 2u + σ 2 + σ 2r
. (20)
Case studies
We compared 10 models using four example case studies
from iRCTs with clustering in one arm: specialist clinics
for the treatment of venous leg ulcers [15], acupuncture
for low back pain [7], cost-effectiveness of community
postnatal support workers (CPSW) [16], and Putting Life
in Years (PLINY) [17]. These studies were selected from
our portfolio of studies as trial statisticians that had clus-
tering in one arm only. The trials are summarised in
Table 2.
Main analysis
The clustering structure of each case study was first
summarised by the number of clusters in the treatment
arm and the mean, median, minimum (min), maximum
(max) and inter-quartile range (IQR) of the cluster size.
All analyses used complete cases for simplicity; patients
with data missing for the primary outcome were removed.
Box plots aided visualisation of the spread of data within
and between each cluster for each case study. Patients
with missing cluster allocation in the treatment arm were
grouped as one cluster in both the summary table and the
box plots.
Model fitting
To explore the practical aspects of the models proposed
for analysing an iRCT with clustering in one arm we
used two statistical packages – Stata and R. The results
presented here are taken from the analysis in R [18]
as Roberts has comprehensively presented results using
Stata [14]. Scripts for both packages are provided (see
Additional file 1).
All models were fitted using a restricted maximum like-
lihood procedure (REML) and the following specifications
of the clustering in the control arm were used:
1. Treating controls as clusters of size one,
2. Treating controls as one large cluster,
3. Creating artificial-clusters.
Although in theory we do not model the clustering in
the control arm for both the partially clustered and het-
eroskedastic models, for the sake of running a model
in R or Stata it is necessary to impose clustering. All
three approaches are explored. The artificial-clusters in
the control arm were created by randomly assigning con-
trol patients to a cluster based on the average cluster size
in the intervention arm.
When analysing clustered data with small to medium
number of clusters, a correction to the degrees of freedom
is recommended to protect against inflation of type I error
[19]. A number of methods which include Satterthwaite
[20] and Kenward-Roger [21] approximations have been
proposed to correct degrees of freedom. The debate about
which procedure to adopt and under what circumstances
is beyond the scope of this paper. In this study, the results
were however similar regardless of whether a correction
to the degrees of freedoms was made or not. In this
regard, the results are presented using REML approxima-
tion without any correction to the degrees of freedom.
However, Stata’s mixed command allows the correction of
degrees of freedom using a number of methods including
Satterthwaite and Kenward-Roger approximations [22].
Using R, the model ignoring clustering was fitted using
the lm() command [18] in the stats package. The lme4
package was used to fit the random effects and the par-
tially clustered model however it was not possible to
use the same package for the heteroskedastic model as
this package does not allow heteroskedastic errors [23].
Instead the nlme and lme() function were used [24].
Bespoke functions were written in R to calculate the ICC
for the appropriate models as per Eqs. 19 and 20.
The lme4 package does not produce p-values for model
estimates and so does not need an estimate for degrees
of freedom. This omission is due to the authors not sup-
porting current approaches for doing so [23]. The nlme
package uses approximations to the distributions of the
maximum likelihood estimates to produce p-values. This
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Fig. 2 Summary of models for the analysis of iRCTs with clustering in one arm only y denotes the continuous outcome, i is the patient indicator, j is
the cluster indicator, t is the treatment indicator variable (t = 1 for the treatment arm and t = 0 for the control arm), θ is treatment effect,  , u and r
are error terms
method requires an estimate of degrees of freedom which
is outlined in detail by Pinheiro and Bates [25].
The results from each model were compared visually
using a forest plot and summarised in a table.
Results
Summary of case studies
Table 3 provides a summary of the four case studies con-
sidered. The CPSW case study has the largest amount of
missing outcome data (13.5%), all patients with no out-
come data were removed from the model fitting. Figure 3
shows there is slight variation in themedian general health
perception domain of the SF-36 with clear differences in
the spread of the data depending on the support worker.
This indicates small potential for clustering of outcomes
in the treatment arm.
The Acupuncture study had an average cluster size of
21 in the intervention arm and 80 patients in the control
arm. As with each of the case studies the controls were
randomly assigned to artificial-clusters. Here four clusters
of size 20 were used. Therapist 7 saw two patients, much
fewer than the other therapists. In Fig. 3 the median pain
score at 12 months varies slightly between the therapists
(not accounting for Therapist 7) and there is little vari-
ability when compared to the control arm. Again there is
potential for clustering of outcomes in the treatment arm.
The outcome of interest in the Ulcer case study is
recorded for all patients in this case study. Figure 3
shows great variability in the median leg ulcer free
weeks between clinics and in comparison to the controls,
indicating potential clustering of the outcome in the treat-
ment arm.
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Table 2 Summary of the case studies
Trial Leg Ulcers Acupuncture CPSW PLINY
Objective Establish clinical effectiveness of
specialist community leg ulcer
clinics versus usual care provided
by district nurses [15]
Determine whether a
short course of traditional
acupuncture improves
longer-term outcomes for
patients with persistent
nonspecific low back
pain [7]
Establish the relative cost-
effectiveness of postnatal
support in the community
in addition to the usual
care provided by
community midwives [16]
Evaluate the effectiveness
and cost-effectiveness of
telephone befriending for
the maintenance of health
related quality of life
(HRQoL) in older people
[17]
Cluster 8 specialist clinics 7 acupuncturists 7 CPSW 5 volunteer facilitators
Outcome of Interest aNumber of ulcer free weeks
during 12 months follow-up
SF-36 pain dimension
measured at 12 months
follow-up [28]
SF-36 general health
perception domain
measured at 6 weeks [28]
SF-36 mental health
dimension score
measured at 6 months
follow-up [28]
Target Difference 10 points 5 points 8 points
Original Analysis – Robust standard errors No adjustment Generalised linear model
with robust standard errors
with participants in the
control arm treated as indi-
vidual clusters of size one
aThis was not the primary outcome in the main study
The PLINY case study was a pliot trial and as such had
an evaluable sample size of 56. There were five patients
in the treatment arm with no cluster allocation. As the
other clusters in the treatment arm were of size six, we
grouped the five patients without cluster allocation into
their own cluster. In Fig. 3, four of these patients hadmiss-
ing outcome data. All clusters contain only a few patients
(a maximum of 6), a reflection of the small sample size
for this study. The small number of patients in each clus-
ter makes it difficult to assess any variability between
facilitators in Fig. 3 and the control arm. There is some
suggestion of variability in the median score in the men-
tal health domain of the SF-36 indicating potential for
clustering in the outcome dependent on the facilitator.
Models
The results from fitting the models to the CPSW case
study are given in Table 4. The estimate of the treatment
difference and its standard error for the model ignoring
clustering and the random effects, partially clustered and
heteroskedastic models are all similar, including for the
various imposed clustering options in the random effects
model. The residual variance is comparable for all these
models and the random variation (where applicable) is
small (<0.0001).
For the random effects model in the remaining case
studies there is some dependence on how the cluster-
ing in the control arm is specified. For example, in the
Acupuncture case study the estimate of the treatment dif-
ference ranges from 5.49 to 5.59 and its standard error
from 3.75 to 5.02 (Table 5). This is evident in the for-
est plot in Fig. 4. A similar result is found for the Ulcer
case study (Table 6) with the standard error greatest when
the controls are treated as one large cluster. The choice
of imposed clustering method also affects the residual
error and the random error. For the PLINY case study
(Table 7) the standard error is largest when the controls
are treated as artificial-clusters. This suggests the specifi-
cation of clustering in the control arm can influence the
results when using a random effects model. A possible
explanation is the small number of patients per cluster. In
the case studies the within cluster variance is estimated
with large uncertainty. As expected, the partially clustered
and heteroskedastic models appear not to depend on the
Table 3 Summary of the clustering in the case studies where IQR is the inter-quartile range. The summary of the cluster sizes is based
on patients with a valid primary endpoint (number analysed)
Total randomised Missing No. analysed (control) No. clusters Mean Median (IQR) (Min, max)
CPSWa 623 84 539 (263) 8 34.5 35.5 (7.25) (22, 46)
Acupuncture 239 24 215 (68) 7 21.0 24.00 (5.00) (2, 27)
Ulcer 233 0 233(113) 8 15.0 13.50 (7.75) (10, 24)
PLINYa 70 14 56 (30) 6 4.3 5.00 (0.75) (1, 6)
aTrial grouped participants with no cluster allocation in the treatment arm into a single cluster
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Fig. 3 Box plot of the case studies. Patients with missing outcome data have been removed
Table 4 Summary of results for the CPSW case study (n = 539)
Model Treatment estimate Standard error Residual variance Random variance Control variance ICC
Ignore clustering -1.62 1.60 343.31
Random effects
Individual clusters of size 1 -1.62 1.60 343.31 <0.0001 <0.0001a
One large cluster -1.62 1.60 343.31 <0.0001 <0.0001a
Artificial-clusters -1.62 1.60 343.31 <0.0001 <0.0001a
Partially clustered
Individual clusters of size 1 -1.62 1.60 343.31 <0.0001 <0.0001b
One large cluster -1.62 1.60 343.31 <0.0001 <0.0001b
Artificial-clusters -1.62 1.60 343.31 <0.0001 <0.0001b
Heteroskedastic
Individual clusters of size 1 -1.62 1.60 339.42 <0.0001 347.38 <0.0001b
One large cluster -1.62 1.60 339.42 <0.0001 347.39 <0.0001b
Artificial-clusters -1.62 1.60 339.42 <0.0001 347.39 <0.0001b
aICC across both arms of the trial
bICC in the intervention arm only
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Table 5 Summary of results for the Acupuncture case study (n = 215)
Model Treatment estimate Standard error Residual variance Random variance Control variance ICC
Ignore clustering 5.69 3.61 604.67
Random effects
Individual clusters of size 1 5.56 3.75 598.68 6.68 0.0110a
One large cluster 5.49 5.02 598.59 10.61 0.0174a
Artificial-clusters 5.59 3.95 599.29 6.63 0.0109a
Partially clustered
Individual clusters of size 1 5.49 3.82 598.59 10.61 0.0174b
One large cluster 5.49 3.82 598.59 10.61 0.0174b
Artificial-clusters 5.49 3.82 598.59 10.61 0.0174b
Heteroskedastic
Individual clusters of size 1 5.54 3.61 649.46 8.56 491.52 0.00744b
One large cluster 5.54 3.61 649.46 8.56 491.52 0.00744b
Artificial-clusters 5.54 3.61 649.46 8.56 491.52 0.00744b
aICC across both arms of the trial
bICC in the intervention arm only
5. Het: Pseudo−random clusters
5. Het:Individual cluster of size 1
5. Het: One large cluster
4. PC: Pseudo−random clusters
4. PC:Individual cluster of size 1
4. PC: One large cluster
3. RE: Pseudo−random clusters
3. RE:Individual cluster of size 1
3. RE: One large cluster
1. Ignore Clustering
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Treatment Difference
(a) Acupuncture (n=215)
5. Het: Pseudo−random clusters
5. Het:Individual cluster of size 1
5. Het: One large cluster
4. PC: Pseudo−random clusters
4. PC:Individual cluster of size 1
4. PC: One large cluster
3. RE: Pseudo−random clusters
3. RE:Individual cluster of size 1
3. RE: One large cluster
1. Ignore Clustering
−2 0 2 4 6 8 10 12 14 16
Treatment Difference
(c) Ulcer (n=233)
5. Het: Pseudo−random clusters
5. Het:Individual cluster of size 1
5. Het: One large cluster
4. PC: Pseudo−random clusters
4. PC:Individual cluster of size 1
4. PC: One large cluster
3. RE: Pseudo−random clusters
3. RE:Individual cluster of size 1
3. RE: One large cluster
1. Ignore Clustering
−4 −2 0 2 4
Treatment Difference
(b) CPSW (n=539)
5. Het: Pseudo−random clusters
5. Het:Individual cluster of size 1
5. Het: One large cluster
4. PC: Pseudo−random clusters
4. PC:Individual cluster of size 1
4. PC: One large cluster
3. RE: Pseudo−random clusters
3. RE:Individual cluster of size 1
3. RE: One large cluster
1. Ignore Clustering
−4 −2 0 2 4 6 8 10 12 14 16 18
Treatment Difference
 (d) PLINY (n=56)
Fig. 4 Forest plot of models fitted using R for each of the case studies where RE is random effects, PC is partial clustering, Het. is heteroskedastic
model. The vertical, black dashed line represents the target treatment difference. We are not using the primary outcome from the Ulcer case study
and so this line is not marked. The vertical, red dotted linemarks a zero treatment difference
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Table 6 Summary of results for the Ulcer case study (n = 233)
Model Treatment estimate Standard error Residual variance Random variance Control variance ICC
Ignore clustering 5.88 2.37 325.66
Random effects
Individual clusters of size 1 6.09 2.66 314.70 11.58 0.0355a
One large cluster 6.12 4.64 319.32 14.19 0.0425a
Artificial-clusters 6.08 2.92 315.18 11.96 0.0366a
Partially clustered
Individual clusters of size 1 6.12 2.72 319.32 14.19 0.0425b
One large cluster 6.12 2.72 319.32 14.19 0.0425b
Artificial-clusters 6.12 2.72 319.32 14.19 0.0425b
Heteroskedastic
Individual clusters of size 1 6.11 2.70 330.21 13.47 308.41 0.0207b
One large cluster 6.11 2.70 330.21 13.47 308.41 0.0207b
Artificial-clusters 6.11 2.70 330.21 13.47 308.41 0.0207b
aICC across both arms of the trial
bICC in the intervention arm only
specification of controls giving identical results regardless
of the approach adopted.
In the case studies considered, the estimates of the ICC
are small with the largest value recorded for the Ulcer
case study of 0.04 (Table 7) estimated using the partially
clustered and random effects model (one large cluster).
These small values may provide an explanation as to
why the simple model ignoring clustering provides similar
estimates to the more complex models in all four cases.
The results were replicated using Stata and the results
were almost identical between the two packages.
Discussion
In this paper, five different approaches to the analysis of
iRCTs with clustering in the treatment arm have been dis-
cussed. Some of these approaches have been applied to
four case studies in different settings to demonstrate their
implementation and evaluate their use in practice.
The four case studies considered have small estimates
for the ICC. All had an ICC less than 0.05 and three stud-
ies had an ICC less than 0.02. This indicates there was
little clustering of outcomes. For example in the CPSW
case studies the General Health Status score of a patient
Table 7 Summary of results for the PLINY case study (n = 56)
Model Treatment estimate Standard error Residual variance Random variance Control variance ICC
Ignore clustering 6.83 5.35 398.13
Random effects
Individual clusters of size 1 6.83 5.35 398.13 <0.0001 <0.0001a
One large cluster 6.83 5.35 398.13 <0.0001 <0.0001a
Artificial-clusters 6.93 5.48 394.01 4.84 0.0121a
Partially clustered
Individual clusters of size 1 6.83 5.35 398.13 <0.0001 <0.0001b
One large cluster 6.83 5.35 398.13 <0.0001 <0.0001b
Artificial-clusters 6.83 5.35 398.13 <0.0001 <0.0001b
Heteroskedastic
Individual clusters of size 1 6.83 5.29 338.50 <0.0001 449.54 <0.0001b
One large cluster 6.83 5.29 338.50 <0.0001 449.54 <0.0001b
Artificial-clusters 6.83 5.29 338.50 <0.0001 449.54 <0.0001b
aICC across both arms of the trial
bICC in the intervention arm only
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seen by SupportWorker 1 would likely be similar had they
been treated by Support Worker 2. As a result of the small
cluster sizes and ICCs, we found little difference in the
estimates of the treatment coefficients and their standard
errors between four of the models. The ICCs observed
in our case studies are not uncommon for trials of this
nature. For example, in surgical trials with a quality of life
endpoint (EQ-5D) identified by Cook et al. there were no
trials with an ICC greater than 0.04 in either intervention
arm [26]. Generally, we would expect the impact of the
ICC to be larger when the therapist effect or cluster based
intervention is delivered over a long period of time (so the
ICC is high) or when the average size of the cluster is large
(the ICC may be small in this case).
The simplest model, ignoring clustering, performed
comparably well with the more complex models for all
case studies. However, it is important to consider that
this model does not truly reflect the design of the study
as there was no allowance for clustering. We would not
expect the simple model to perform well in circumstances
where the ICC is higher or the cluster size is large. We
do not recommend this model for use in practice, how-
ever, applying this model to our case studies illustrated
that there was little difference in the results using the cor-
rect, more complex methods and so the results previously
found are still valid.
Although in theory we might anticipate differences in
the outcome of patients dependent on the cluster they
belong to, in reality the ICC is often low as we observed
in our case studies. One explanation could be, in clini-
cal research practice, the training given to therapists as
part of the protocol in some way standardises the treat-
ment given. If the ICC was high there might be concern
regarding the success of the intervention as there would
be a strong reliance on the cluster and the therapist or
healthcare professional delivering the intervention. We
encourage the reporting of the ICC from clinical trials to
aid the planning of future studies.
When using a random effects model to analyse cluster-
ing in just one arm of a study it is necessary to specify how
the control arm is treated. In our results we found that for
three of the case studies the choice of clustering for con-
trols influenced the treatment coefficient estimates and
their corresponding standard errors. Although this model
performed well in our case, it does not truly represent the
nature of clustering in the trial as we have forced clusters
in the control arm that were not present in the actual trial.
Therefore we do not recommend this approach.
The partially clustered and heteroskedastic models
more accurately reflect the clustering in these trials, how-
ever, are of greater statistical complexity. We are often
required to specify in advance of the trial commencing
the proposed analysis. This is before any data from the
trial has been collected so we do not know the ICC in the
study. Therefore balancing the complexity of the model
fitting procedure and the gain in accuracy of the results,
we recommend to use the partially clustered model as
a minimum, as this provides an accurate analysis of the
study regardless of the observed ICC. We recommend, to
allow fitting of the partially clustered models, participants
in the unclustered arm are treated a clusters of size one as
this provides a simple and intuitive solution for practical
implementation.
If there is strong belief that there are different variances
between the treatments and controls the heteroskedastic
approach may be appropriate. We hope to identify, in a
simulation study, a threshold value for the expected differ-
ence in individual level variability between the treatment
and control arm whereby the heteroskedastic model will
be more appropriate. Practically, fitting the partially clus-
tered and heteroskedastic models in R and Stata required
little additional work and the code to implement these
models is provided.
Limitations
This study employed a formal search of relevant literature
to capture most of the related work conducted. However,
this was not an exhaustive review of all work in this area.
We have used four case studies that have arisen from
our work as applied medical statisticians in clinical trials
research. The results and inferences made are applicable
to data with similar properties to these studies. For exam-
ple our results focus only on continuous endpoints and
as discussed relate to trials with small ICCs and relatively
small clusters. All the case studies assumed each patient
belonged to one cluster only; in the Acupuncture study
patients only saw one therapist. We have not considered
the effects of multiple membership [27].
Our analysis of these case studies was on complete cases
only, we have ignored any data collected on patients for
whom the outcome of interest was not recorded. The
cluster allocation for participants in some of the case stud-
ies were also missing and we were not able to find this
information. We therefore had to group these participants
into one cluster. These data limitations may result in a
large loss of information and potentially introduce bias,
so alternative approaches should be explored. While small
cluster sizes, small ICCs and incomplete data are issues in
many real world data sets, to increase the generalisabil-
ity of these results to trials with different characteristics
to the case studies we hope to conduct a simulation study.
This study will explore how the findings might change for
varying cluster sizes, varying ICC, varying sample sizes
and differential variance in the control and intervention
arms.
We believe that while the control arm is ‘unclustered’,
there is low level, natural clustering that occurs in practice
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in all trials - even trials with no formal clustering in either
arm. For instance, patients in the unclustered control may
be treated within the same hospital by healthcare pro-
fessionals with similar skill levels or even by the same
healthcare professional, creating potential dependencies
in their outcomes. Baldwin et al. state that it is not plau-
sible to have a non-zero ICC for the unclustered controls
[5]. In their work they treat each individual in the cluster
arm as their own cluster and conclude that the ICC for
unclustered participants will have a negligible impact on
estimation. Here we have considered clustering the con-
trols as one large group cluster and using artificial clusters.
We acknowledge that imposing these types of clusterings
in the control arm that does not exist in reality could
impact the estimation of the ICC. By imposing cluster-
ing on the control arm of the study we may impact the
estimation of the ICC as we are either over or underesti-
mating this low level natural clustering that is occurring.
We will explore the impact of this imposed clustering on
estimation in a simulation study.
In the analysis of cRCTs two popular methods of
analysis include the use of random effects models and
marginal models [2]. In this work we have chosen to
use random effects models as this allowed the fitting of
the more complex partially clustered and heteroskedastic
models.
Conclusions
In iRCTs where the treatment is group based or delivered
by a health professional there is potential for a cluster-
ing of outcomes in the treatment arm only. As with any
clustering this needs special attention in the design and
analysis of the study. This paper has summarised the liter-
ature, identifying five potential approaches for the analysis
of trials where there is clustering in one arm only. Some
of these methods have been applied using the statisti-
cal packages R and Stata, exploring alternative methods
to model the clustering in the control arm, to four case
studies where clustering was present in one arm. Ignor-
ing the clustering performed well for our case studies as
a consequence of the low ICC in these studies. However,
we do not recommend this approach in practice. Mod-
elling homogeneous variances between the clustered and
unclustered arm is adequate in scenarios similar to the
case studies considered. We recommend treating each
participant in the unclustered arm as a single cluster to
facilitate modelling in a statistical package. This approach
is simple to implement in R and Stata and is recommended
for the analysis of trials with clustering in one arm only.
The generalisability of our results is limited to trials sim-
ilar to the case studies. Simulation work is required, for
example, to determine scenarios where accounting for
different levels of variability between treatment arms is
necessary.
Additional file
Additional file 1: Generic code. R and Stata code for models and ICC
calculations. This file contains the R and Stata code required to implement
the models used throughout this article. (DOCX 22 kb)
Abbreviations
CPSW: Community Postnatal Support Worker; cRCT: Cluster randomised
controlled trial; FE: Fixed Effects; GP: General Practitioner; Het: Heteroskedastic;
ICC: Intra-cluster correlation coefficient; IQR: Inter-quartile range; iRCT:
Individually randomised controlled trial; Min: Minimum; Max: Maximum; PC:
Partially clustered; PLINY: Putting life in years; RCT: Randomised controlled trial;
RE: Random effects
Acknowledgments
Not applicable.
Funding
This is independent research arising from grants: Research Methods
Fellowship (RMFI-2013-04-011 Goodacre) and Doctoral Research Fellowship
(DRF-2012-05-182) which are funded by the National Institute for Health
Research fully supporting LF and MD respectively. AA, MD, LM and SW were
funded by the University of Sheffield.
Availability of data andmaterials
Data used here are from published trials so will be made available on request
by contacting the corresponding author. However, availability is conditional
on an agreement with individual Chief Investigators.
Authors’ contributions
SW and MD conceived the project and designed the work. EL and LF carried
out the literature search. EL and MD devised the notation for the statistical
models. LF and AA summarised the datasets and AA and LM wrote the R code
for the fitting of statistical models. All R code was checked by LM for accuracy.
EL wrote the Stata code for the fitting of the statistical models. LF drafted the
manuscript. All authors contributed to the writing of the manuscript, its
revisions and approved the final version.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
This is secondary analysis of trial data which has been published. Individual
ethics approvals for the trials used were obtained as noted in related
publications which have been referenced.
Disclaimer
The views expressed in this publication are those of the authors and not
necessarily those of the NHS, National Institute for Health Research, the
Department of Health or the University of Sheffield.
Author details
1ScHARR, University of Sheffield, 30 Regent Street, S1 4DA Sheffield, UK. 2MRC
Biostatistics Unit, Cambridge Institute of Public Health, Forvie Site, Robinson
Way, Cambridge Biomedical Campus, CB2 0SR Cambridge, UK.
Received: 11 January 2016 Accepted: 17 October 2016
References
1. Walters SJ. Therapist effects in randomised controlled trials: what to do
about them. J Clin Nurs. 2010;19:1102–1112.
2. Campbell MJ, Walters SJ. How to Design, Analyses and Report Cluster
Randomised Trials in Medicine and Health Related Research. West Sussex:
Statistics in Practice, Wiley; 2014.
3. Campbell MJ, Machin D, Walters SJ. Medical Statistics. A Textbook for the
Health Sciences, 4th Edition. Chester: Wiley; 2007.
Flight et al. BMCMedical ResearchMethodology  (2016) 16:165 Page 13 of 13
4. Baldwin SA, Stice E, Rohde P. Statistical analysis of group-administered
intervention data: Reanalysis of two randomized trials. Psychother Res.
2008;18(4):365–76.
5. Baldwin SA, Bauer DJ. Evaluating models for partially clustered designs.
Psychol Methods. 2011;16:149–65.
6. Weatherley-Jones E, Nicholl JP, Thomas KJ, Parry GJ, McKendrick MW,
Green ST, Stanley PJ, Lynch SPJ. A randomised,controlled, triple-blind
trial of the efficacy of homeopathic treatment for chronic fatigue
syndrome. J Psychosom Res. 2004;56:189–97.
7. Thomas KJ, MacPherson H, Thorpe L, Brazier J, Fitter M, Campbell MJ,
Roman M, Walters SJ, Nicholl J. Randomised controlled trial of a short
course of traditional acupuncture compared with usual care for persistent
non-specific low back pain. BMJ. 2006;333:623.
8. Bauer DJ, Sterba SK, Hallfors DD. Evaluating group-based interventions
when control participants are ungrouped. Multivar Behav Res. 2008;43:
210–36.
9. Bland M. Grouping in individually randomised trials. In: 4th Annual
Conference on Randomised Controlled Trials in the Social Sciences,
September 2009. York, UK; 2009. https://www-users.york.ac.uk/~mb55/
talks/. Accessed 31 Oct 2016.
10. Heo M, Litwin AH, Blackstock O, Kim N, Arnsten JH. Sample size
determinations for group-based randomized clinical trials with different
levels of data hierarchy between experimental and control arms. Stat
Methods Med Res. 2014;0:1–15.
11. Galbraith S, Daniel JA, Vissel B. A study of clustered data and approaches
to its analysis. J Neurosci. 2010;30(32):10601–10608.
12. Faes MC, Reelick MF, Perry M, Rikkert MGO, Borm GF. Studies with
group treatments required special power calculations, allocation
methods, and statistical analyses. J Clin Epidemiol. 2012;65(2):138–46.
13. Moerbeek M, Wong WK. Sample size formulae for trials comparing group
and individual treatments in a multilevel model. Stat Med. 2008;27:
2850–864.
14. Roberts C. Session 3: Design and analysis of trials of therapist treatments.
In: BABCP 2010, 38th Annual Conference and Workshops; 2010. Available
online at http://slideplayer.com/slide/6195114/. Accessed 31 Oct 2016.
15. Morrell CJ, Walters SJ, Dixon S, Collins KA, Brereton LML, Peters J,
Brooker CGD. Cost effectiveness of community leg ulcer clinics:
randomised controlled trial. BMJ. 1998;316:1487–1497.
16. Morrell CJ, Spiby H, Stewart P, Walters S, Morgan A. Costs and
effectiveness of community postnatal support workers: randomised
controlled trial. BMJ. 2000;321:593–8.
17. Gail M, Hind D, Gossage-Worrall R, Walters S, Duncan R, Newbould L,
Rex S, Jones C, Bowling A, Cattan M, Cairns A, Cooper C, Edwards R,
Goyder E. ’Putting Life in Years’ (PLINY) telephone friendship groups
research study: pilot randomised controlled trial. Trials. 2014;15(1):141.
18. R Core Team. R: A Language and Environment for Statistical Computing.
Vienna: R Foundation for Statistical Computing; 2013. R Foundation for
Statistical Computing. http://www.R-project.org/.
19. Kahan BC, Forbes G, Ali Y, Jairath V, Bremner S, Harhay MO, Hooper R,
Wright N, Eldridge SM, Leyrat C. Increased risk of type i errors in cluster
randomised trials with small or medium numbers of clusters: a review,
reanalysis, and simulation study. Trials. 2016;17(1):438.
20. Satterthwaite FE. An approximate distribution of estimates of variance
components. Biom Bull. 1946;2(6):110–4.
21. Kenward MG, Roger JH. Small sample inference for fixed effects from
restricted maximum likelihood. Biometrics. 1997;53(3):983–997.
22. StataCorp. Stata: Release 14. statistical software. 2015. http://www.stata.
com/support/faqs/resources/citing-software-documentation-faqs/.
23. Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models
using lme4. J Stat Softw. 2015;67(1):1–48. doi:10.18637/jss.v067.i01.
24. Pinheiro J, Bates D, DebRoy S, Sarkar D, R Core Team. nlme: Linear and
Nonlinear Mixed Effects Models. 2015. R package version 3.1-121. http://
CRAN.R-project.org/package=nlme. Accessed 31 Oct 2016.
25. Pinheiro J, Bates D. Mixed-effects models in S and S-PLUS. Springer
Science & Business Media. 2006.
26. Cook JA, Bruckner T, MacLennan GS, Seiler CM. Clustering in surgical
trials-database of intracluster correlations. Trials. 2012;13(1):1.
27. Browne WJ, Goldstein H, Rasbash J. Multiple membership multiple
classification (MMMC) models. Stat Model. 2001;1(2):103–24.
28. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey
(SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:
473–83.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
